MGFA 与 生物新闻o 特色 重症肌无力新闻 在我们的网站上发布资讯,为社区提供研究进展、疾病管理见解和相关新闻。所有内容均为原创,由Bionews编辑团队制作,并包含患者和护理人员的观点。这些信息并非旨在替代或提供医疗建议。
重症肌无力新闻 – 重症肌无力新闻网络每日资源
- MDA Engage: National ambassador brings message of belonging, resilienceby 塔拉Haelle 在10月15,在2026:12下午00
Lily Sander will never forget what it was like to meet other people with neuromuscular diseases the first time she attended Muscular Dystrophy Association (MDA) Summer Camp. Living with Charcot-Marie-Tooth disease, Sander had met only one or two other people with neuromuscular diseases in her city. She was used to explaining why she used a The post MDA Engage: National ambassador brings message of belonging, resilience appeared first on Myasthenia Gravis News.
- gMG treatments show varied benefits across response measuresby 米凯拉·卢西亚诺博士 在10月14,在2026:3下午30
Approved and experimental targeted treatments for generalized myasthenia gravis (gMG) show different patterns of benefit across measures of treatment response, according to an indirect comparison analysis of clinical trial data. Using mathematical models to account for differences in dosing schedules, researchers found that individual therapies differed in their maximum benefit, speed of response, and cumulative The post gMG treatments show varied benefits across response measures appeared first on Myasthenia Gravis News.
- Like a donkey, my MG body is stubborn, but it has also carried meby 马克哈灵顿 在10月14,在2026:2下午00
On Oct. 4, I turned 66. The 4th is also the feast day of St. Francis of Assisi. For most of my life, I also shared it with my Aunt Kay. As a boy in Malden, Massachusetts, I thought that was a fine piece of luck. A saint who preached to birds and tamed a The post Like a donkey, my MG body is stubborn, but it has also carried me appeared first on Myasthenia Gravis News.
- 2 strategies for treating gMG each work with 1 treatment, study findsby Patricia Inacio 博士 在10月13,在2026:12下午45
A new study comparing outcomes of two different strategies for treating generalized myasthenia gravis (gMG) found that both the approved med Vyvgart (efgartigimod alfa) and a blood-cleaning procedure called double-filtration plasmapheresis (DFPP) were generally equally effective in easing symptoms. Both treatments significantly reduced disease-causing antibodies and improved daily function in people living with gMG, the data The post 2 strategies for treating gMG each work with 1 treatment, study finds appeared first on Myasthenia Gravis News.
- When healthcare language fails myasthenia gravis patients in crisisby 肖娜·巴恩斯 在10月12,在2026:2下午00
Breathing is supposed to be automatic. Invisible. Effortless. Most people never think about the mechanics behind it — the diaphragm pulling down, the rib cage expanding, the air moving in and out like a tide. But for some of us living with myasthenia gravis (MG), those mechanics take center stage. They become the diva demanding The post When healthcare language fails myasthenia gravis patients in crisis appeared first on Myasthenia Gravis News.
** MGFA 免责声明 – 请阅读
美国重症肌无力基金会 (MGFA) 和 Bionews, Inc.(具体为重症肌无力新闻)已达成有限协议,允许 MGFA 在 myasthenia.org 网站上发布重症肌无力新闻的链接。重症肌无力新闻是一个数字平台,旨在为重症肌无力 (MG) 社区提供有关 MG 的最新新闻和信息,以及来自患者和护理人员专栏作家的第一手社区观点。重症肌无力新闻上的所有文章均为内部作家和编辑撰写的原创内容。偶尔,Bionews 会征求外部专家的意见,进行采访和问答。
重症肌无力新闻的出版团队由科学作家和编辑组成,其中大多数拥有生命科学博士学位;资深记者;以及重症肌无力社区的专栏作家。他们共同努力,确保重症肌无力新闻上发布的所有内容都具有相关性、准确性、信息量大、可关联且易于理解。
每篇内容均由 Bionews 撰稿人精心挑选和撰写,以 MG 社区为中心。新闻报道和资源页面的来源包括同行评审的研究、新闻稿、公告、访谈、网络研讨会和会议等。所有文章都经过严格的事实核查和编辑程序,这是 Bionews 流程的一部分,以确保其准确、客观、全面且解释清楚。
专栏由重症肌无力患者和护理人员撰写,他们深入剖析了身患重症肌无力的生活。虽然专栏主要是观点和看法,但每篇专栏仍经过 Bionews 编辑的全面编辑和事实核查,以确保清晰、准确和公正。
重症肌无力新闻网站是一个专门介绍该疾病的新闻和信息的网站。它不提供医疗建议、诊断或治疗。本内容并非旨在替代专业医疗建议、诊断或治疗。如果您对医疗状况有任何疑问,请务必咨询有执照的医生或其他合格的医疗服务提供者。切勿因为在本网站上读到的内容而忽视专业医疗建议或延迟寻求专业医疗建议。所提供的信息仅供教育之用,不能替代专业医疗建议。
内容反映了作者的独特经历,不一定代表 MGFA 的意见、观点或建议。与 MGFA 相关或合作的医疗顾问和临床医生不会对发布在重症肌无力新闻平台或网站上的文章和信息进行同行评审。MGFA 不对发布在重症肌无力新闻网站上的任何信息、意见、文章、建议、指导或详细信息负责。MGFA 已将此平台发布为 MG 社区服务。请咨询您的医生和医疗保健专业人员,以获取与您的医疗保健/治疗有关的具体建议和意见。





